AKT1 and cerebral cavernous malformation: Kahn et al. recently demonstrated that CCM-associated gene loss of function and PIK3CA gain of function both activated PI3K/AKT/mTOR signaling and that inhibitors targeting this signaling pathway could prevent CCM formation in mice8.